MIM
CALA

MetLife Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

MetLife Investment Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-627
Closed -$61.6K – 2347
2020
Q4 		$61.6K Buy
627
+453
+260% +$39.7K ﹤0.01% 2249
2020
Q3 		$12K Sell
174
-1,201
-87% -$105K ﹤0.01% 2288
2020
Q2 		$145K Hold
1,375
– – ﹤0.01% 2069
2020
Q1 		$122K Buy
+1,375
New +$164K ﹤0.01% 1971

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's CALA Position: Q1 2021 in Review

MetLife Investment Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 627 shares — an estimated $61.6K sold.

MetLife Investment Management first reported a position in CALA in Q1 2020 and held it in 4 quarters. The position peaked at $145K in Q2 2020. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

  • MetLife Investment Management reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
  • MetLife Investment Management sold 627 Calithera Biosciences, Inc shares in Q1 2021, an estimated $61.6K.
  • MetLife Investment Management first reported a position in Calithera Biosciences, Inc in Q1 2020 and held it in 4 quarters.
  • MetLife Investment Management's Calithera Biosciences, Inc position peaked at $145K in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.